多中心EVAR术后监测评估研究(EVAR-SCREEN)
EVAR-SCREEN多中心研究评估英国EVAR术后监测依从性及其对再干预和生存的影响,发现依从率66%,中心间差异大(9%-88%),年龄和距医院距离是非依从独立预测因素。非依从患者术后前3年全因死亡率较低,但依从患者术后4-5年全因死亡率较低(p<.001),再干预率无显著差异。
要点
- 英国EVAR术后监测依从率为66%,中心间差异大(9%-88%)。
- 年龄和距医院距离是非依从的独立预测因素。
- 依从患者术后4-5年全因死亡率较低,再干预率无差异。
核心结论
- 英国EVAR术后监测依从性为66%,中心间差异大(9%-88%)。
- 年龄和距医院距离是非依从独立预测因素。
- 非依从患者前3年全因死亡率较低,依从患者4-5年全因死亡率较低(p<.001)。
- 依从与非依从患者再干预率无显著差异。
研究设计与样本
- 非依从定义为存在单个18个月期间未进行监测影像学检查。
- 研究结束时378例患者有5年随访数据可供分析。
主要发现
- 监测依从率为66%(61%-68%),中心间范围9%-88%。
- 年龄(HR 1.03,95%CI 1.01-1.05;p=.02)和距医院距离(HR 1.01,95%CI 1.00-1.01;p<.001)是非依从独立预测因素。
- 非依从患者EVAR后前3年全因死亡率较低,依从患者EVAR后4-5年全因死亡率较低(p<.001)。
- 依从与非依从患者再干预率无显著差异。
临床怎么用
- 应关注EVAR术后监测依从性,尤其对高龄和距医院远的患者。
- 中心间依从性差异大,需优化随访服务提供方式。
- 依从性与EVAR术后远期生存获益相关,对EVAR服务规划有启示。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Surveillance imaging is considered mandatory after endovascular aneurysm repair (EVAR), but many patients are lost to follow up and the impact of this is poorly understood. This study aimed to examine compliance with post-operative surveillance in the UK and the impact of mal-/non-compliance on endograft re-interventions and survival. METHODS: EVAR-SCREEN centres reported EVAR for intact infrarenal abdominal aortic aneurysms (AAA) from 1 January 2007 to 31 December 2010, with follow up included up to 31 July 2014. Non-compliance was defined by the presence of a single 18 month period in which no surveillance imaging was performed. The outcomes were reported in compliant and non-compliant groups with survival analysis. RESULTS: EVAR was performed in 1414 patients in 10 UK centres. At the end of the study period there were 378 patients with five years of follow up available for analysis. Compliance with surveillance was 66% (61-68%). Compliance varied widely, from 9% to 88% between centres. Age (hazard ratio [HR] 1.03, 95% confidence interval [CI] 1.01-1.05; p = .02) and distance from hospital (HR 1.01, 95% CI 1.00-1.01; p < .001) were independent predictors of non-compliance. Non-compliant patients had lower all cause mortality in the first three years after EVAR, whereas compliant patients had lower all cause mortality 4-5 years after EVAR (p < .001). No significant difference in re-intervention rates was found between compliant and non-compliant patients. CONCLUSION: A substantial proportion of patients were non-compliant with surveillance after EVAR in the UK with considerable variation between centres. The survival benefit for EVAR after three years appeared to be related to compliance with surveillance which has implications for the future delivery of EVAR.
引用
- Grima MJ, Karthikesalingam A, Holt PJ, et al. Multicentre Post-EVAR Surveillance Evaluation Study (EVAR-SCREEN). Eur J Vasc Endovasc Surg. 2019. PMID: 30738734. doi:10.1016/j.ejvs.2018.10.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。